Latest filing published 29 Apr 2021 for Impel Neuropharma INC, €1.1M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Norwest Venture Partners XIV, LP: trading record in brief
All filings by Norwest Venture Partners XIV, LP on record concern Impel Neuropharma Inc. The record holds 3 filings, all for trades on 27 April 2021.
On the market, this insider has only ever bought: 1 purchase, €10.2M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 29 April 2021, reports a transaction of €1.1M in Impel Neuropharma Inc. The last insider purchase was made public on 29 April 2021, 2,020 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Norwest Venture Partners XIV, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 98,927 shares@ US$13.509.7% of flowCommon StockSEC:0001209191-21-029115:0
- 2,153,271 shares0Common StockSEC:0001209191-21-029115:1
- 825,000 shares@ US$15.0090.3% of flowCommon StockSEC:0001209191-21-029115:2Canonical exit: 26 Jul 2021 (T+90)
3 of 3 declarations
